Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: The ABLATIVE-2 trial—a study protocol

A delta-radiomic lymph node model using dynamic contrast enhanced MRI for the early prediction of axillary response after neoadjuvant chemotherapy in breast cancer patients

13 p | 8 | 3

MET and PTEN gene copy numbers and Ki-67 protein expression associate with pathologic complete response in ERBB2- positive breast carcinoma patients treated with neoadjuvant trastuzumab-based therapy

11 p | 17 | 2

Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer

11 p | 8 | 1

A nomogram based on platelet-tolymphocyte ratio for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy

9 p | 4 | 1

The use of longitudinal CT-based radiomics and clinicopathological features predicts the pathological complete response of metastasized axillary lymph nodes in breast cancer

13 p | 2 | 1